MedPath

Oxford Biomedical Technologies, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)

Not Applicable
Active, not recruiting
Conditions
IBS - Irritable Bowel Syndrome
First Posted Date
2022-01-05
Last Posted Date
2025-05-25
Lead Sponsor
Oxford Biomedical Technologies, Inc.
Target Recruit Count
60
Registration Number
NCT05178017
Locations
🇺🇸

Oxford Biomedical Technologies, Inc., Riviera Beach, Florida, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.